Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1962 2
1971 1
1980 1
1985 1
1989 2
1991 1
1992 1
1998 1
2004 1
2005 1
2007 2
2009 1
2014 2
2015 3
2018 3
2019 8
2020 14
2021 20
2022 22
2023 16
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
The history of lupus throughout the ages.
Felten R, Lipsker D, Sibilia J, Chasset F, Arnaud L. Felten R, et al. J Am Acad Dermatol. 2022 Dec;87(6):1361-1369. doi: 10.1016/j.jaad.2020.04.150. Epub 2020 May 4. J Am Acad Dermatol. 2022. PMID: 32380218 Review.
[A review of avascular necrosis, of the hip and beyond].
Pijnenburg L, Felten R, Javier RM. Pijnenburg L, et al. Among authors: felten r. Rev Med Interne. 2020 Jan;41(1):27-36. doi: 10.1016/j.revmed.2019.10.332. Epub 2019 Nov 10. Rev Med Interne. 2020. PMID: 31722835 Review. French.
New and future therapies: Changes in the therapeutic armamentarium for SLE.
Askanase A, Khalili L, Tang W, Mertz P, Scherlinger M, Sebbag E, Chasset F, Felten R, Arnaud L. Askanase A, et al. Among authors: felten r. Best Pract Res Clin Rheumatol. 2023 Dec;37(4):101865. doi: 10.1016/j.berh.2023.101865. Epub 2023 Aug 24. Best Pract Res Clin Rheumatol. 2023. PMID: 37633826 Review.
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.
Devauchelle-Pensec V, Carvajal-Alegria G, Dernis E, Richez C, Truchetet ME, Wendling D, Toussirot E, Perdriger A, Gottenberg JE, Felten R, Fautrel BJ, Chiche L, Hilliquin P, Le Henaff C, Dervieux B, Direz G, Chary-Valckenaere I, Cornec D, Guellec D, Marhadour T, Nowak E, Saraux A. Devauchelle-Pensec V, et al. Among authors: felten r. JAMA. 2022 Sep 20;328(11):1053-1062. doi: 10.1001/jama.2022.15459. JAMA. 2022. PMID: 36125471 Clinical Trial.
Non-primary Sjogren's Syndrome: Secondary or associated?
Felten R, Meyer A, Gottenberg JE. Felten R, et al. Joint Bone Spine. 2023 Mar;90(2):105502. doi: 10.1016/j.jbspin.2022.105502. Epub 2022 Dec 1. Joint Bone Spine. 2023. PMID: 36464213 No abstract available.
Examining the biological pathways underlying clinical heterogeneity in Sjogren's syndrome: proteomic and network analysis.
Berry JS, Tarn J, Casement J, Duret PM, Scott L, Wood K, Johnsen SJ, Nordmark G, Devauchelle-Pensec V, Seror R, Fisher B, Barone F, Bowman SJ, Bombardieri M, Lendrem D, Felten R, Gottenberg JE, Ng WF. Berry JS, et al. Among authors: felten r. Ann Rheum Dis. 2024 Jan 2;83(1):88-95. doi: 10.1136/ard-2023-224503. Ann Rheum Dis. 2024. PMID: 37657927
99 results